Gene therapy returns to centre stage
- PMID: 26469046
- DOI: 10.1038/nature15818
Gene therapy returns to centre stage
Abstract
Recent clinical trials of gene therapy have shown remarkable therapeutic benefits and an excellent safety record. They provide evidence for the long-sought promise of gene therapy to deliver 'cures' for some otherwise terminal or severely disabling conditions. Behind these advances lie improved vector designs that enable the safe delivery of therapeutic genes to specific cells. Technologies for editing genes and correcting inherited mutations, the engagement of stem cells to regenerate tissues and the effective exploitation of powerful immune responses to fight cancer are also contributing to the revitalization of gene therapy.
Similar articles
-
Toward Clinical Translation of New Gene Targeting Technologies for Correcting Inherited Mutations and Empowering Adoptive Immunotherapy of Cancer (SUPERSIST).Hum Gene Ther Clin Dev. 2015 Jun;26(2):95-7. doi: 10.1089/humc.2015.2529. Hum Gene Ther Clin Dev. 2015. PMID: 26086760 No abstract available.
-
IND-Enabling Studies for a Clinical Trial to Genetically Program a Persistent Cancer-Targeted Immune System.Clin Cancer Res. 2019 Feb 1;25(3):1000-1011. doi: 10.1158/1078-0432.CCR-18-0963. Epub 2018 Nov 8. Clin Cancer Res. 2019. PMID: 30409823 Free PMC article.
-
Retroviral Vectors for Cancer Gene Therapy.Recent Results Cancer Res. 2016;209:17-35. doi: 10.1007/978-3-319-42934-2_2. Recent Results Cancer Res. 2016. PMID: 28101685 Review.
-
Contributions of gene marking to cell and gene therapies.Hum Gene Ther. 2011 Jun;22(6):659-68. doi: 10.1089/hum.2010.237. Epub 2011 May 5. Hum Gene Ther. 2011. PMID: 21261461 Free PMC article. Review.
-
Hematopoietic Stem Cell Approaches to Cancer.Hematol Oncol Clin North Am. 2017 Oct;31(5):897-912. doi: 10.1016/j.hoc.2017.06.012. Hematol Oncol Clin North Am. 2017. PMID: 28895855 Review.
Cited by
-
A novel multikinase inhibitor SKLB-YTH-60 ameliorates inflammation and fibrosis in bleomycin-induced lung fibrosis mouse models.Cell Prolif. 2021 Jul;54(7):e13081. doi: 10.1111/cpr.13081. Epub 2021 Jun 14. Cell Prolif. 2021. PMID: 34121240 Free PMC article.
-
Nucleic Acid Immunotherapeutics for Cancer.ACS Appl Bio Mater. 2020 May 18;3(5):2838-2849. doi: 10.1021/acsabm.0c00101. Epub 2020 Mar 16. ACS Appl Bio Mater. 2020. PMID: 33681722 Free PMC article.
-
Azeliragon ameliorates Alzheimer's disease via the Janus tyrosine kinase and signal transducer and activator of transcription signaling pathway.Clinics (Sao Paulo). 2021 Mar 8;76:e2348. doi: 10.6061/clinics/2021/e2348. eCollection 2021. Clinics (Sao Paulo). 2021. PMID: 33681944 Free PMC article.
-
Regulation and targeting of SREBP-1 in hepatocellular carcinoma.Cancer Metastasis Rev. 2024 Jun;43(2):673-708. doi: 10.1007/s10555-023-10156-5. Epub 2023 Dec 1. Cancer Metastasis Rev. 2024. PMID: 38036934 Free PMC article. Review.
-
COLEC12 regulates apoptosis of osteosarcoma through Toll-like receptor 4-activated inflammation.J Clin Lab Anal. 2020 Nov;34(11):e23469. doi: 10.1002/jcla.23469. Epub 2020 Aug 21. J Clin Lab Anal. 2020. PMID: 32822099 Free PMC article.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical